By: Frank Angst The Minnesota Racing Commission has reached settlements to resolve three high-level positives found in recent equine post-race drug tests. Two of the positives were for pemoline (Cylert), and one was for cardarine—both substances that call for the highest level of sanctions according to industry standards. The MRC cited mitigating circumstances as the
By: Natalie Voss From Dec. 28 to Dec 30, 2015, inspectors from Florida's Department of Health observed business at Ergogenic Labs in Wellington, Fla., where pharmacist Scott Mangini oversaw the compounding of human and animal drugs. The inspectors were not happy with what they found. In a subsequent report dated Jan. 5, 2016, they “noted
By Blood-Horse Staff The Association of Racing Commissioners International Sept. 29 announced members of a committee that will work with regulators in each racing state to complete implementation of reforms that make up the National Uniform Medication Program. The 12 members of the ARCI Compliance Committee were invited by ARCI chairman Mark Lamberth, who has
By Tom LaMarra In an unusual development, Canterbury Park has come to the defense of top trainer McLean Robertson, who was suspended for 90 days and fined $2,000 by the Minnesota Racing Commission for a positive test for a Class 1 methamphetamine. The Minneapolis Star-Tribune earlier reported that Robertson, also the leading trainer at Delaware
NEWS RELEASE December 3, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC: CURRENT THRESHOLD LEVELS FOR CORTICOSTEROIDS, CLENBUTEROL SHOULD REMAIN The Racing Medication & Testing Consortium (RMTC) is releasing two position papers which stated that no physiologic difference among the various racing breeds exists to justify changing regulatory thresholds from those recently established by the
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
